Medical Weight Loss for Maple Grove, Minnesota Residents

Maple Grove, Minnesota residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Maple Grove through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Open to all of Minnesota, including Maple Grove: our Costa Mesa, California physicians treat patients statewide by telehealth, so distance from our office never changes the care you receive. Doctor review just $119 (medication separate).

Why Maple Grove Residents Choose New Hope Weight Loss

We are built for people who would rather not deal with insurance at all. New Hope is cash-pay friendly, so there are no prior authorizations, no denials, and no waiting on a carrier to decide what you are allowed to try. Patients in Maple Grove pay a flat physician fee of $119 and a clear monthly medication price, and we accept HSA, FSA, Klarna, and Affirm so the cost can fit your budget without a fight.

Maple Grove residents do not need a local clinic to start. Our physician-led program is delivered by secure video from Costa Mesa, California, with flat nationwide pricing and compounded medication mailed in cold-pack packaging to your Maple Grove address.

You do not need a clinic on your street in Maple Grove to work with a real physician, because everything Dr. Sharma offers from Costa Mesa reaches patients across Minnesota by secure telehealth. We care for patients throughout Maple Grove and the northwestern Minneapolis metro of Hennepin County. There is no distance surcharge for living outside Costa Mesa, and we accept HSA, FSA, Klarna, and Affirm to make starting easier across Minnesota.

A patient in the busiest part of Maple Grove and one in a quiet Minnesota suburb pay exactly the same: $119 for the physician review and semaglutide from $166 per month. If you would rather spread payments out, Maple Grove patients can use Klarna or Affirm at checkout instead of paying the full cost at once. Wherever you live in Minnesota, New Hope Weight Loss provides physician-supervised GLP-1 care by secure telehealth from our Costa Mesa, California clinic, with no travel required.

GLP-1 Weight Loss Programs Available

Two GLP-1 paths, one plan built around you

The 90-Day Metabolic Reset uses semaglutide, the same active ingredient in Wegovy and Ozempic. From $166 a month, or $499 for the full 90 days, it pairs medication with monthly check-ins. Branded-drug trials showed average loss of about 15 to 17 percent. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary from person to person.

Want a stronger option? Ask about tirzepatide

From $233 a month, tirzepatide combines GLP-1 and GIP action. Trial participants on qualifying doses saw up to 22.5 percent body-weight loss, a top-dose number rather than the average. It carries the same active ingredient as Mounjaro and Zepbound.

Your $119 physician review comes first. Medication is billed separately. HSA, FSA, Klarna, and Affirm are all welcome for Maple Grove patients.

How Telehealth Works for Maple Grove

Think of it as four easy moments. You begin with an online intake quiz that asks about your weight, your health history, and what you want to achieve. Dr. Anjmun Sharma then reviews your answers and meets you by secure video, generally within 48 hours, to talk honestly about whether compounded semaglutide or tirzepatide could help you. If she prescribes one, a state-licensed 503(a) pharmacy fills it and ships it to your Maple Grove address in protective cold-pack packaging. Finally, your follow-up care is delivered by video, so people throughout can stay on plan without ever sitting in a waiting room.

Frequently Asked Questions, Maple Grove

Does New Hope Weight Loss have a presence in Maple Grove?

Our presence in Maple Grove is through telehealth rather than a storefront. The clinic itself is in Costa Mesa, California, our sole physical location. We serve Maple Grove, Minnesota patients online, and Dr. Anjmun Sharma confirms your eligibility for compounded semaglutide or tirzepatide during a private video consultation.

Could a Maple Grove patient complete care without leaving home?

Yes, staying home is the norm. Everything for Maple Grove patients runs over telehealth, including the initial consult, dose adjustments, and check-ins. After approval, your medication travels to Maple Grove in insulated cold-pack shipping that protects it from temperature swings during delivery.

How are Maple Grove patients charged?

There is a $119 fee for the physician review. Semaglutide starts at $166 monthly, with a 90-day option at $499, and tirzepatide at $233 monthly. The medication itself is a separate cost. We accept HSA, FSA, Klarna, and Affirm, and we add no distance surcharge for Maple Grove.

What areas of Maple Grove do you serve?

We serve patients from across Maple Grove by telehealth, including Maple Grove and the northwestern Minneapolis metro of Hennepin County.

What makes this different from a local Maple Grove medspa or clinic?

A named, licensed physician, Dr. Anjmun Sharma, supervises every case. Contraindications are screened at intake, the 503(a) compounding pharmacy is identified, and pricing is flat and stated up front. Maple Grove patients get a real physician-led medical practice by telehealth, not a quick membership sign-up.

Maple Grove Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Maple Grove, Minnesota by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.